Point72 Asset Management, L.P. - ARCUTIS BIOTHERAPEUTICS INC ownership

ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 109 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.4%.

Quarter-by-quarter ownership
Point72 Asset Management, L.P. ownership history of ARCUTIS BIOTHERAPEUTICS INC
ValueSharesWeighting
Q4 2022$16,332,925
-77.4%
1,103,576
-70.8%
0.06%
-80.6%
Q3 2022$72,337,000
+70.8%
3,785,277
+90.5%
0.29%
+61.5%
Q2 2022$42,352,000
+29.5%
1,987,431
+17.1%
0.18%
+37.7%
Q1 2022$32,701,000
-40.4%
1,697,849
-35.8%
0.13%
-40.6%
Q4 2021$54,840,000
+15.2%
2,644,177
+32.7%
0.22%
+4.8%
Q3 2021$47,591,000
+94.5%
1,992,107
+122.2%
0.21%
+90.0%
Q2 2021$24,463,000
+92.5%
896,400
+104.1%
0.11%
+86.4%
Q1 2021$12,709,000
-48.4%
439,300
-49.8%
0.06%
-50.8%
Q4 2020$24,619,000
+1843.1%
875,200
+1923.3%
0.12%
+1900.0%
Q3 2020$1,267,00043,2560.01%
Other shareholders
ARCUTIS BIOTHERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Frazier Life Sciences Management, L.P. 8,684,232$46,113,2723.06%
Pivotal bioVenture Partners Investment Advisor LLC 1,105,309$5,869,1912.34%
Bain Capital Life Sciences Investors, LLC 3,000,000$15,930,0001.78%
Sio Capital Management, LLC 635,969$3,376,9951.04%
Rubric Capital Management LP 5,034,530$26,733,3541.00%
Tejara Capital Ltd 309,179$1,641,7400.93%
AlphaCentric Advisors LLC 165,000$876,1500.50%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,135,227$6,028,0550.33%
Orbimed Advisors 1,914,479$10,165,8830.22%
Two Seas Capital LP 164,807$875,1250.18%
View complete list of ARCUTIS BIOTHERAPEUTICS INC shareholders